Modal Therapeutics, co-founded by Arkin Bio, is a pioneering biotech company focused on developing antibody-based therapeutics that target TGFβ biology.
Arkin Entry Stage
Discovery
Status
Active
Location
Boston, MA
Let’s get in touch!
